274 related articles for article (PubMed ID: 22563057)
1. Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis.
Jaeger LB; Nath A
Dis Model Mech; 2012 May; 5(3):313-22. PubMed ID: 22563057
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy.
Lamers SL; Fogel GB; Nolan DJ; McGrath MS; Salemi M
Biosystems; 2014 May; 119():53-61. PubMed ID: 24732754
[TBL] [Abstract][Full Text] [Related]
3. HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.
Saylor D; Dickens AM; Sacktor N; Haughey N; Slusher B; Pletnikov M; Mankowski JL; Brown A; Volsky DJ; McArthur JC
Nat Rev Neurol; 2016 Apr; 12(4):234-48. PubMed ID: 26965674
[TBL] [Abstract][Full Text] [Related]
4. HIV-Associated Neurologic Disorders and Central Nervous System Opportunistic Infections in HIV.
Le LT; Spudich SS
Semin Neurol; 2016 Aug; 36(4):373-81. PubMed ID: 27643907
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Experimental Models of HIV-Associated Neurological Disorders.
Sil S; Periyasamy P; Thangaraj A; Niu F; Chemparathy DT; Buch S
Curr HIV/AIDS Rep; 2021 Oct; 18(5):459-474. PubMed ID: 34427869
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Opioids on HIV Neuropathogenesis.
Murphy A; Barbaro J; Martínez-Aguado P; Chilunda V; Jaureguiberry-Bravo M; Berman JW
Front Immunol; 2019; 10():2445. PubMed ID: 31681322
[TBL] [Abstract][Full Text] [Related]
7. Update on HIV-associated neurocognitive disorders.
Alfahad TB; Nath A
Curr Neurol Neurosci Rep; 2013 Oct; 13(10):387. PubMed ID: 23954972
[TBL] [Abstract][Full Text] [Related]
8. HIV and neurocognitive dysfunction.
Spudich S
Curr HIV/AIDS Rep; 2013 Sep; 10(3):235-43. PubMed ID: 23860944
[TBL] [Abstract][Full Text] [Related]
9. Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.
Crowell CS; Malee KM; Yogev R; Muller WJ
Rev Med Virol; 2014 Sep; 24(5):316-31. PubMed ID: 24806816
[TBL] [Abstract][Full Text] [Related]
10. [Neurocognitive disorders related to human immunodeficiency virus infection].
Muñoz-Moreno JA; Blanch Andreu J
Med Clin (Barc); 2009 May; 132(20):787-91. PubMed ID: 19361818
[TBL] [Abstract][Full Text] [Related]
11. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
12. HIV infection of the central nervous system: clinical features and neuropathogenesis.
Boissé L; Gill MJ; Power C
Neurol Clin; 2008 Aug; 26(3):799-819, x. PubMed ID: 18657727
[TBL] [Abstract][Full Text] [Related]
13. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J; Tyor W
J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
[TBL] [Abstract][Full Text] [Related]
14. Animal models of HIV-associated disease of the central nervous system.
Mallard J; Williams KC
Handb Clin Neurol; 2018; 152():41-53. PubMed ID: 29604983
[TBL] [Abstract][Full Text] [Related]
15. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
[TBL] [Abstract][Full Text] [Related]
16. Rodent models for HIV-associated neurocognitive disorders.
Gorantla S; Poluektova L; Gendelman HE
Trends Neurosci; 2012 Mar; 35(3):197-208. PubMed ID: 22305769
[TBL] [Abstract][Full Text] [Related]
17. Role of neuroimaging in HIV-associated neurocognitive disorders.
Masters MC; Ances BM
Semin Neurol; 2014 Feb; 34(1):89-102. PubMed ID: 24715492
[TBL] [Abstract][Full Text] [Related]
18. Neurologic Complications in Treated HIV-1 Infection.
Bhatia NS; Chow FC
Curr Neurol Neurosci Rep; 2016 Jul; 16(7):62. PubMed ID: 27170369
[TBL] [Abstract][Full Text] [Related]
19. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals.
Ceccarelli G; Brenchley JM; Cavallari EN; Scheri GC; Fratino M; Pinacchio C; Schietroma I; Fard SN; Scagnolari C; Mezzaroma I; Vullo V; d'Ettorre G
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29160817
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus and the central nervous system.
Mirza A; Rathore MH
Semin Pediatr Neurol; 2012 Sep; 19(3):119-23. PubMed ID: 22889541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
